Nasopharyngeal carcinoma (NPC), which is closely associated with Epstein-Barr virus (EBV), is a metastasis-prone epithelial cancer. We previously showed that tumor necrosis factor a-induced protein 2 (TNFAIP2) is highly expressed in NPC tumor tissues and is correlated with metastasis and poor survival in NPC patients. However, the underlying mechanism remains unclear. In this study, we demonstrate that the EBV oncoprotein, latent membrane protein 1 (LMP1), can transcriptionally induce TNFAIP2 expression via NF-kB. Quantitative RT-PCR and western blotting revealed that LMP1 induces TNFAIP2 expression through its C-terminal-activating region (CTAR2) domain, which is required for transduction of NF-kB (nuclear factor kappa-light-chain-enhancer of activated B cells) signaling. Inhibition of NF-kB activation or depletion of p65 (a component of NF-kB) by RNA interference abolished the LMP1-induced expression of TNFAIP2, whereas ectopic expression of p65 was sufficient to induce TNFAIP2 expression. Luciferase reporter assays showed that LMP1 transcriptionally induces TNFAIP2 expression through a newly identified NF-kB-binding site within the TNFAIP2 promoter ( À 3 869 to À 3 860 bp). Immunohistochemical analysis of NPC biopsy specimens further revealed a significant correlation between the protein levels of TNFAIP2 and activated p65 (R ¼ 0.689, Po0.001), indicating that our findings are clinically relevant. Immunofluorescence microscopy and co-immunoprecipitation assays showed that TNFAIP2 associates with actin and is involved in the formation of actin-based membrane protrusions. Furthermore, transwell migration assays demonstrated that TNFAIP2 contributes to LMP1-induced cell motility. Collectively, these findings provide novel insights into the regulation of TNFAIP2 and its role in promoting NPC tumor progression.
INTRODUCTION
Nasopharyngeal carcinoma (NPC) is a malignant epithelial tumor prevalent in Taiwan and southeastern China. 1, 2 Among the headand-neck squamous cell carcinomas, NPC has the highest preponderance for regional lymph node metastasis. 3 Although the current treatment regimes for NPC have achieved survival rate around 50% in 5 years, 20-25% of patients eventually develop distant metastases. 4, 5 In addition to environmental and genetic factors, Epstein-Barr virus (EBV) infection is highly associated with NPC development. 6, 7 As an ubiquitous g-herpes virus, EBV can establish a latent infection that may be seen among humans worldwide. 8 Relatively few viral genes are expressed during latency; among them, latent membrane protein 1 (LMP1) is detected in 50-80% of NPC specimens (the rates vary depending on the detection method). 9, 10 LMP1 is an integral membrane protein with a short N-terminus, six transmembrane domains and a long C-terminal tail that contains three major functional domains called C-terminalactivating region (CTAR) domains 1-3. 11 Through the CTAR domains, LMP1 engages various cellular factors to transduce multiple signaling pathways, including the nuclear factor-kappa B (NF-kB)-, p38 mitogen-activated protein kinase (MAPK)-, c-Jun N-terminal kinase-and extracellular response kinase (ERK) 1/2-mediated signaling pathways. 11, 12 LMP1 is mimetic in that it acts like a constitutively activated member of the tumor necrosis factor receptor family. It possesses the ability to transform primary B lymphocytes 13 and rodent fibroblasts, 14 and it contributes to NPC development through cell proliferation, antiapoptosis, cell migration, invasion and angiogenesis. [15] [16] [17] [18] Tumor necrosis factor a-induced protein 2 (TNFAIP2, also called B94 or M-sec) was originally identified as a TNFa-inducible gene in endothelial cells. 19 It was subsequently shown to be induced in an in vitro model of angiogenesis, 19 suggesting that it has an angiogenic role. Despite the reported involvements of TNFAIP2 in antiviral responses, 20 cell apoptosis 21 and tunneling nanotube formation, 22 the molecular basis for the functional regulation of TNFAIP2 remains largely unknown. We previously demonstrated that overexpression of TNFAIP2 in NPC tissues is significantly correlated with tumor metastasis and poor survival for NPC patients, 23 linking TNFAIP2 to tumor progression. In this study, we further investigate the mechanisms underlying the dysregulation of TNFAIP2 in NPC. Our findings reveal that LMP1 induces TNFAIP2 expression via NF-kB-activated transcription. Moreover, TNFAIP2 associates with actin and modulates its organization, thereby contributing to LMP1-mediated cell migration.
RESULTS
LMP1 is a potent inducer of TNFAIP2 expression NPC progression is highly associated with EBV infection, and NPC tumors can be poorly oxygenated, nutrient-deprived and infiltrated with pro-inflammatory cells. 24, 25 Using western blot analysis, we sought to investigate whether various tumor-related factors (for example, hypoxia, serum deprivation, cytokine stimulation and LMP1 expression) could induce TNFAIP2 expression at the protein level. Among the tested factors, LMP1 triggered the most potent induction of TNFAIP2 expression in NPC-TW02 cells (B4.6-fold versus the empty vector control; Supplementary Figure 1a) . TNFa also induced TNFAIP2 expression, albeit to a lower extent (1.8-fold versus the blank control). We next used quantitative RT-PCR to analyze the mRNA levels of TNFAIP2 in 18 NPC clinical specimens and tested for correlation with LMP1 and/or TNFa expression. As shown in Supplementary Figure 1b , the mRNA level of TNFAIP2 was approximately two-fold higher in specimens that were either LMP1-positive or TNF high (n ¼ 10) compared with that in LMP1-negative/TNF low samples (n ¼ 8). These findings indicate that induction of TNFAIP2 expression by LMP1 or TNFa is clinically relevant.
To assess the effect of LMP1 on TNFAIP2 expression in greater detail, we transfected various amounts of an LMP1-expressing vector into NPC-TW02 cells and used quantitative RT-PCR and western blotting to examine TNFAIP2 expression at the mRNA and protein levels, respectively. As shown in Supplementary Figures 2a  and 2b , LMP1 dose-dependently induced TNFAIP2 expression at the mRNA and protein levels. The LMP1-induced expression of TNFAIP2 mRNA peaked at 12 h post transfection ( Supplementary  Figure 2c) , whereas the increased protein expression of TNFAIP2 was sustained to 48 h post transfection (Supplementary Figure 2d) . We further confirmed the LMP1-mediated induction of TNFAIP2 expression in several NPC cell lines (NPC-TW01, -TW04 and HK1), indicating that the observed effect was not cell line-specific (Figures 1a and b) .
To verify the upregulation of TNFAIP2 in EBV-positive NPC cells, we analyzed the mRNA and protein levels of TNFAIP2 in HK1-EBV cells, in which an EBV genome was stably maintained and LMP1 expression was detectable. 26 Our experiments confirmed that the mRNA and protein levels of TNFAIP2 were around two-fold higher in HK1-EBV cells compared with parental HK1 cells (Figures 1c and  d) . Moreover, small interfering RNA (siRNA)-mediated knockdown of LMP1 reduced TNFAIP2 expression by B20% at the mRNA level ( Figure 1e ) and the protein level (Figure 1f ) in HK1-EBV cells. These relatively moderate reductions in TNFAIP2, which probably reflected a low efficacy of LMP1 depletion, were nonetheless significant, demonstrating that LMP1 is a potent inducer of TNFAIP2 expression in NPC.
The CTAR2 domain of LMP1 is crucial for the induction of TNFAIP2 To dissect the functional domains of LMP1 for the induction of TNFAIP2, we analyzed TNFAIP2 expression in NPC-TW02 cells expressing various forms of truncated or mutated LMP1 ( Figure 2a -TW01, -TW02, -TW04 and  HK1 cells) were individually transfected with 2 mg of plasmids encoding Flag-LMP1 or the empty vector (pCMV-Flag). At 24 h post transfection, the levels of TNFAIP2 transcripts were measured using quantitative RT-PCR. The results were normalized with respect to the levels of GADPH transcripts. The TNFAIP2 mRNA level in pCMV-Flag-transfected cells was set as 1. (b) The TNFAIP2 protein levels in the above samples were examined using western blotting. The results were quantified using the ImageQuant software (Molecular Dynamics, Sunnyvale, CA, USA) and normalized with respect to tubulin. The relative level of TNFAIP2 protein in pCMV-Flag-transfected cells was set as 1. (c and d) HK1 or HK1-EBV cells were cultured under normal conditions, and RNA (c) and protein (d) samples were harvested and assessed using quantitative RT-PCR and western blotting, respectively, as described above. (e and f ) HK1-EBV cells were transfected with control or LMP1-targeting siRNA and cultured for 48 h. The relative expression levels of TNFAIP2 mRNA (e) and protein (f ) were determined as described above. All data are shown as the mean ± s.d. of at least three experiments; *Po0.05.
reduced the LMP1-mediated induction of TNFAIP2 at both the mRNA and protein levels (by B65% compared with the induction by the full-length LMP1). A functionally defective mutation of the CTAR1 domain (mCTAR1; denoted M5) had no effect on the induction of TNFAIP2 by LMP1, but M5 coupled with the YYD deletion (denoted M6) completely abolished the ability of LMP1 to induce TNFAIP2, indicating that the CTAR1 domain has a supportive role. In line with this, an LMP1 construct lacking the C-terminal region encompassing the CTAR1 and CTAR2 domains (DCTerm; denoted M4) failed to induce TNFAIP2 expression.
Together, these data demonstrate that LMP1 mainly relies on its CTAR2 domain to induce TNFAIP2 expression. LMP1 induces TNFAIP2 expression via NF-kB activation LMP1 is known to activate NF-kB and the MAPK-mediated pathway through the CTAR2 domain. 11 In addition, we previously showed that LMP1 activates NF-kB, c-Jun N-terminal kinase, p38 MAPK and ERK signaling in NPC-TW02 cells. 27 Here, we used inhibitors of the above signaling pathways (BAY11-7082, SP600125, SB203580 and PD98059, respectively) to identify which pathway is responsible for the LMP1-mediated induction of TNFAIP2 expression. Treatment with an NF-kB inhibitor (BAY11-7082) significantly reduced the LMP1-mediated induction of TNFAIP2 expression (by B75% compared with the vehicle control; Figure 3a ). In addition, treatment with a p38 MAPK inhibitor (SB203580) slightly decreased the LMP1-mediated induction of TNFAIP2. We further used siRNAmediated RNA interference to deplete the key molecules necessary for these signaling pathways. Our results revealed that depletion of p65, a major component of NF-kB, abolished the LMP1-induced expression of TNFAIP2 compared with the experiments performed with control siRNA (Figure 3b ). Consistent with this finding, coexpression of a dominant-negative mutant of I-kBa, which is known to block NF-kB activation, dose-dependently inhibited the LMP1-mediated induction of TNFAIP2 (Figure 3c ). In contrast, ectopic expression of p65 was sufficient to dose-dependently induce TNFAIP2 expression (Figure 3d ), but a promoter-bindingdefective mutant of p65 (Y23A, E26D) failed to show this effect. Collectively, these data show that LMP1 induces TNFAIP2 expression via NF-kB activation.
The protein level of TNFAIP2 is significantly correlated with the activation of p65 in NPC biopsy tissues We next conducted immunohistochemical staining to analyze the protein expression levels of TNFAIP2, LMP1 and activated p65 in consecutive sections of NPC biopsy specimens. A specific p65 antibody (designed to recognize an epitope overlapping the nuclear location signal) was used to monitor the nuclear translocation of p65 upon activation. Consistent with the cellbased data (Figures 1-3 ), TNFAIP2 protein expression, LMP1 protein expression, and p65 activation were observed in EBVpositive NPC tumor cells, in which EBV-encoded small RNAs were detected (Figure 4a ). Furthermore, the expression level of TNFAIP2 was significantly correlated with the activation of p65, as assessed in consecutive sections of NPC biopsy samples from 30 patients (R ¼ 0.689, Po0.001; Figures 4b and c) . These findings reinforce the notion that NF-kB activation is clinically significant for the upregulation of TNFAIP2 in NPC.
LMP1 upregulates TNFAIP2 transcription through a conserved NF-kB-binding motif within the TNFAIP2 promoter To clarify whether NF-kB mediates the LMP1-induced expression of TNFAIP2 at the promoter level, we first analyzed the nucleotide sequence upstream of the TNFAIP2 gene using the UCSC website (http://genome.ucsc.edu/). On the basis of the prediction of the ENCODE consortium 2012, we identified a conserved NF-kB (nuclear factor kappa-light-chain-enhancer of activated B cells)-binding site located 3869 base pairs (bp) upstream of the TNFAIP2 transcription start site ( À 3869 to À 3860). We thus generated two TNFAIP2 promoter constructs with a luciferase reporter ( Figure 5a) ; one contained the 4002 bp upstream of the TNFAIP2 transcription start site (denoted À 4002), whereas the other lacked the NF-kBbinding site (denoted À 3797). Luciferase reporter assays demonstrated that both constructs exhibited approximately a five-fold increase in promoter activity compared with the promoter-less control (pGL3) in NPC-TW02 cells expressing empty pCMV-Flag ( Figure 5b ). Notably, LMP1 expression led to an B12-fold increase in activity from the À 4002 promoter, but only an approximately six-fold increase in activity from the À 3797 promoter, indicating that NF-kB is involved in this promoter activation. Consistent with this, introduction of mutations into the NF-kB-binding site Figure 2 . Mapping of the LMP1 domains responsible for the upregulation of TNFAIP2. (a) Schematic demonstration of LMP1 and its derivative constructs. LMP1 contains a short N-terminus, transmembrane domains and a C-terminal region harboring CTAR1, CTAR2 and CTAR3. A detailed description of these functional domains was reported previously. 27 (b and c) NPC-TW02 cells were transfected with 2 mg of plasmids encoding Flag-LMP1, the indicated derivative or the vector (pCMV-Flag; denoted C). At 24 h post transfection, the mRNA (b) and protein (c) levels of TNFAIP2 were determined using quantitative RT-PCR and western blotting, respectively, and calculated as described above. The expression level of TNFAIP2 in pCMV-Flag-transfected cells was set as 1. All data are shown as the mean±s.d. of at least three experiments. The band with higher molecular weight (*) in M4 LMP1 mutant could result from a hydrophobic association between the C-terminus-truncated LMP1 proteins, which is estimated to be 20 kDa (the lower band).
(NF-kB-m1 or NF-kB-m2) abolished the LMP1-induced activity of the À 4002 promoter (Figure 5c ). Moreover, ectopic expression of p65 was sufficient to induce activity from the wild-type À 4002 promoter (B10-fold activation) but not from either of the NF-kBbinding defective mutants ( Figure 3d ). As expected, the DNAbinding defective p65 (Y23A, E26D) was unable to induce activity from the À 4002 promoter (Figure 5e ). Collectively, these results indicate that LMP1 upregulates the transcription of TNFAIP2 via the activation of NF-kB.
TNFAIP2 is apparently localized at the actin-based membrane protrusions as well as in the nucleus To examine the effect of LMP1 on TNFAIP2 expression inside cells, we performed immunofluorescence staining of endogenous TNFAIP2 in NPC-TW02 cells expressing LMP1-mCherry and visualized the results using confocal microscopy. As shown in Figure 6a , the fluorescence intensity of TNFAIP2 was significantly increased in LMP1-expressing cells compared with neighboring cells lacking LMP1 expression. Moreover, TNFAIP2 was localized in the nucleus and at the membrane ruffles and protrusions. This expression pattern was similar to that observed for ectopic EGFP (enhanced green-fluorescent protein)-TNFAIP2 ( Figure 6b ). As membrane structures usually form via actin organization, we examined whether the TNFAIP2-positive membrane protrusions were associated with actin filaments (F-actin). Fluorescence staining for F-actin with TRITC-conjugated phalloidin revealed that EGFP-TNFAIP2 was perfectly colocalized with actin-based protrusions at the cell membrane ( Figure 6b ). These results suggest that TNFAIP2 may participate in cellular processes involving actin.
Actin-associated TNFAIP2 is involved in the formation of actin-based protrusions We next investigated whether TNFAIP2 could affect actin organization in NPC cells. We used TNFAIP2 siRNA to knock down the endogenous TNFAIP2 protein expression in NPC-TW02 cells and Figure 3 . NF-kB activation is required for LMP1-induced TNFAIP2 expression. (a) NPC-TW02 cells were transfected with pCMV-Flag vector (denoted C) or pFlag-LMP1 for 6 h and then treated with an inhibitor of NF-kB (BAY11-7082), c-Jun N-terminal kinase (SP600125), p38 MAPK (SB203580) or ERK1/2 (PD98059), with DMSO used as the vehicle (DO). After 24 h, the cells were lysed and subjected to western blotting and the data were quantified as described above. The protein level of TNFAIP2 in the vector-transfected, DMSO-treated cells was set as 1. (b) NPC-TW02 cells were pretreated with control siRNA or siRNA targeting p65, c-Jun, p38a/b or Erk1/2, and then further transfected with pCMV-Flag or pFlag-LMP1 for 48 h. The protein level of TNFAIP2 in each group was analyzed and quantified as described; the level in cells transfected with control siRNA and pCMV-Flag (denoted C) was set as 1. (c) Cells were cotransfected with pCMV-Flag or pFlag-LMP1, together with various amounts (0.5, 1 and 2 mg) of plasmids for a dominant-negative (dn) I-kBa mutant. After 24 h, the protein level of TNFAIP2 in each group was analyzed and quantified as described above. The TNFAIP2 level in cells transfected with pCMV-Flag alone was set as 1. (d) NPC-TW02 cells were transfected with various amounts (0.33, 1 and 3 mg) of plasmids encoding wild-type (WT) or mutated (Y23A, E26D) p65. Cells transfected with the empty pCDNA3 vector were used as a control (denoted C). The protein level of TNFAIP2 in each group was analyzed and quantified as described above, with the level in the vector control set as 1; *Po0.05. examined actin filament organization using fluorescence confocal microscopy. As shown in Figure 7a , actin protrusions (X10 mm in length; see inset) were frequently observed in control siRNAtreated cells (Ctrl-si) grown at subconfluence. Notably, a portion of TNFAIP2 was localized at these actin structures (Figure 7a, inset) . In contrast, TNFAIP2 siRNA-treated cells (TNFAIP2-si) had fewer of these protrusions, even though the actin protein level remained unchanged (Figure 7b ). To comprehensively quantify the morphological effects of TNFAIP2 depletion, we acquired whole-slide images of control siRNA-and TNFAIP2 siRNA-treated cells using an IN Cell Analyzer 2000 (GE Healthcare Life Sciences, Taipei, Taiwan) (for details, see Materials and Methods). We found that TNFAIP2 depletion reduced the percentage of cells showing longer actin protrusions (X10 mm) from 59 to 34% (Figure 7c) , and decreased the average length of the actin protrusions (Figure 7d ). On the basis of these findings, we hypothesized that TNFAIP2 might associate with actin, thereby modulating the formation of actin protrusions. To verify this, we performed a co-immunoprecipitation assay in which protein G beads coupled with an anti-TNFAIP2 antibody were used to precipitate TNFAIP2 protein complexes from NPC-TW02 cells. Western blotting revealed that actin was present in the TNFAIP2-precipitated complexes (Figure 7e ), indicating that there is an association between TNFAIP2 and actin. Collectively, these data demonstrate that TNFAIP2 is associated with actin and is involved in the formation of actinbased protrusions.
TNFAIP2 has a migration-promoting effect that contributes to LMP1-induced cell motility Cell motility is initiated by an actin-dependent protrusion at the leading edge. The coordinated polymerization of actin filaments against cellular membranes provides the force for a number of processes, such as cell migration. 28 The elongation of the actin filaments by actin polymerization toward the plasma membrane provides a driving force that pushes the cell edge forward and is the key step in cell migration. 28, 29 On the basis of the morphological effects of TNFAIP2 on actin filaments (Figure 7 ) and the clinical relevance of TNFAIP2 to NPC metastasis, 23 we speculated that TNFAIP2 could affect cell motility by modulating actin organization. Indeed, our transwell migration assays showed that siRNA-mediated depletion of TNFAIP2 reduced the migration ability of NPC-TW02 cells by B50% (Figures 8a and b; pCMV-Flag/Ctrl-si versus pCMV-Flag/TNFAIP2-si). Expression of LMP1 enabled the cells to migrate vigorously (a six-fold increase; Flag-LMP1/Ctrl-si versus pCMV-Flag/Ctrl-si), whereas depletion of TNFAIP2 reduced the LMP1-induced cell motility by 50% (Figures 8a and b ; Flag-LMP1/TNFAIP2-si versus Flag-LMP1/Ctrl-si). In line with these results, the cells expressing EGFP-LMP1, which were incubated under a condition similar to the transwell migration assays, showed a clear formation of actin-based protrusions compared with the cells expressing EGFP alone (Figure 8c, upper panel) . Moreover, depletion of TNFAIP2 impaired the formation of such actin protrusions (Figure 8c, bottom panel) . These data suggest that the upregulation of TNFAIP2 contributed to LMP1-mediated cell motility-a process involving the remodeling of actin filaments. To test that enhanced expression of TNFAIP2 indeed promotes cell motility, we performed transwell migration assays using NPC-TW02 cells transfected with a TNFAIP2-expressing vector (TNFAIP2-IRES-EGFP). Our results revealed that enhanced expression of TNFAIP2 increased the migration ability of NPC-TW02 cells by two-fold compared with vector (pIRES2-EGFP)-expressing cells (Figures 8d and e) . Consistently, an increased formation of actin protrusions was detected in LMP1 induces migration-promoting TNFAIP2 via NF-kB C-C Chen et al these cells ectopically expressing TNFAIP2 (Figure 8f ). Collectively, our data reveal that TNFAIP2 has a migration-promoting effect that contributes to the LMP1-induced NPC cell motility.
DISCUSSION
We previously showed that TNFAIP2 is highly expressed in NPC tissues and is significantly correlated with a poor distant metastasis-free survival in NPC patients, showing its potential as an independent prognostic marker. 23 In this study, we further provide the molecular basis for the functional regulation of TNFAIP2 and its correlation with clinical significance. We reveal for the first time that EBV-encoded LMP1 potently induces TNFAIP2 expression via NF-kB-driven transcription. Moreover, we demonstrate that TNFAIP2 associates with actin and promotes cell migration, probably by modulating actin organization. In this way, the upregulation of TNFAIP2 contributes to LMP1-induced cell motility ( Figure 9) . TNFAIP2 expression appears to be tightly regulated during development, as its mRNA is highly expressed in the developing hematopoietic tissues but is absent from most adult tissues 30 except for myeloid-lineage dendritic cells and macrophages. 22 Notably, TNFAIP2 mRNA expression is induced in a variety of cell types under certain conditions, including treatment with interleukin-1b, 19 retinoic acid, 21,31,32 androgen 33 or hydrogen peroxide, 34 overexpression of the erythroblastic leukemia viral oncogene homolog 2 35 and infection with human T-cell leukemia virus type 1. 36 These findings suggest that TNFAIP2 may have important yet uncharacterized roles in the cellular responses to various stimulations, and its expression could be regulated in developmental and cell type-specific manners. Consistent with this, we found that TNFa but not IFNg could induce TNFAIP2 expression in NPC-TW02 cells (Supplementary Figure 1a) , whereas the opposite effect was previously observed in rat macrophages (Raw264.7 cells). 22 Furthermore, we observed that LMP1, which is considered to be a viral mimic of a tumor necrosis factor receptor family member, substantially induced TNFAIP2 expression (Figures  1-5 ; Supplementary Figures 1a and 2 ) through the activation of NF-kB (Figures 3-5) , suggesting that TNFa is likely to induce TNFAIP2 expression via the same pathway. In any case, the activation of NF-kB contributes to the upregulation of TNFAIP2 in NPC, as reflected by the significant correlation observed between TNFAIP2 expression and NF-kB activity in clinical NPC specimens (Figure 4) .
Induction of TNFAIP2 mRNA expression by NF-kB-mediated signaling has also been reported in monocytes, 37 reinforcing the notion that NF-kB has a primary role in the transcriptional upregulation of TNFAIP2. The present study is the first one to identify the NF-kB-binding site that is essential for the NF-kBdriven transcription of TNFAIP2 ( Figure 5 ). This binding motif is located upstream of the TNFAIP2 gene ( À 3869 to À 3860 bp) near a proximal RNA polymerase II-binding site ( À 3122 to À 2542 bp), as assessed using the ENCODE consortium. Notably, two binding elements for the CCCTC-binding factor are located in the 3 0 -flanking region of the RNA polymerase II-binding site. The CCCTCbinding factor has a well-known role in chromatin organization and can function as a barrier or insulator by connecting multiple repressive elements together. 38 It is likely that the CCCTC-binding factor could regulate TNFAIP2 expression by modulating the structure of the TNFAIP2 gene. 39 This may reflect, at least in part, the stringent regulation that is required for TNFAIP2 to properly fulfill its developmental role.
We further report that TNFAIP2 associates with actin and is involved in the formation of actin-based membrane protrusions in NPC cells (Figures 6, 7 and 8f ), indicating that TNFAIP2 has an effect on actin remodeling. In line with this notion, previous studies revealed that TNFAIP2 is essential for the formation of membrane nanotubes, 22 which are long (X10 mm in length), actin-based tubular connections that allow the exchange of cellular surface molecules and cytoplasmic content between remote cells. 22, [40] [41] [42] Although the molecular basis for the formation of the nanotubes remains unclear, TNFAIP2 likely coordinates with active RalA (a Rasrelated small GTPase) and the exocyst complex to initiate this process. 22 Furthermore, RalA, through its interaction with Ralbinding protein 1, could be able to activate the Rho small GTPase Cdc42, which is a central factor for the induction of actin remodeling 28, 43 and seems to be required for the extension of the nanotubes. 22, 40 The proposed functions for these nanotubes include the cell-to-cell transfer of membrane vesicles and signal transduction molecules in a wide variety of cell types. [44] [45] [46] Moreover, some pathogens have been shown to exploit the related structures to spread among cells, [47] [48] [49] [50] and TNFAIP2 mRNA expression appears to be upregulated under conditions known to enhance nanotube formation. 34, 36, 51, 52 It is not yet clear whether the TNFAIP2-modulated actin protrusions in NPC cells are functionally related to the reported actin-based nanotubes; however, both the actin-based protrusive structures may share the same underlying mechanism that engages the actinremodeling proteins, such as Cdc42. In our previous study, we have revealed that LMP1 is able to activate Cdc42 by directly binding to FGD4, thereby promoting the migration of NPC cells. 16 In this study, we found that elevated expression of TNFAIP2 also contributes to the LMP1-mediated cell motility (Figures 8a and b) . Notably, depletion of Cdc42 appeared to eliminate the TNFAIP2-promoted cell motility (our unpublished data), indicating that actin remodeling is required for this effect of TNFAIP2. It will be interesting to investigate how TNFAIP2 coordinates with Cdc42 to modulate the actin remodeling in NPC cells, and whether LMP1 Figure 6 . Expression patterns of TNFAIP2 in NPC cells. (a) NPC-TW02 cells transfected with pcDNA3.1-LMP1-mCherry (1 mg) were grown for 24 h and then trypsinized and seeded onto coverslips. After 24 h, the cells were fixed and incubated with a TNFAIP2 antibody followed by an Alexa Fluor 488-conjugated secondary antibody for staining of endogenous TNFAIP2. Nuclei were stained with DAPI. Images were acquired using a ZEISS LSM510 META laser-scanning confocal microscope (Carl Zeiss) with a Â 63/1.32 NA oil-immersion objective. Scale bar, 20 mm. Inset shows images acquired at higher magnification. (b) NPC-TW02 cells transfected with pEGFP-TNFAIP2 (1 mg) were grown and fixed as described above and then incubated with TRITC-conjugated phalloidin for staining of actin filaments (F-actin). Images were acquired as described above. Scale bar, 20 mm.
induces the TNFAIP2-mediated formation of nanotubes participating in tumor progression.
A few other recent reports have described the expression patterns of TNFAIP2 and assessed its potential value for distinguishing cancer types 53 or predicting cancer risk, 54, 55 providing additional evidence that TNFAIP2 is relevant to cancer pathogenesis. Despite its homology to Sec6 (a component of the exocyst complex), TNFAIP2 does not associate with the exocyst components 22 or have a well-defined protein domain. In the future, it will be useful to further explore the functions of TNFAIP2 by identifying its interacting partners. Given that NPC is a highly metastatic cancer associated with EBV infection, clarifying the role of TNFAIP2 in NPC cells should accelerate our understanding of the physiological processes in which TNFAIP2 participates, such as actin remodeling and cell migration. This could lead to the identification of new therapeutic targets that may be exploited to limit or eradicate diseases and infections in the body.
MATERIALS AND METHODS

Clinical specimens
The utilized retrospective cohort compromised 48 NPC patients who had been admitted to the Chang Gung Memorial Hospital (Lin-Kou, Taiwan). This research was reviewed and approved by the institutional review board and ethics committee of the Chang Gung University. Informed consent was obtained from all patients.
Cell culture, reagents and CaPO 4 -based transfection
The utilized NPC cell lines (NPC-TW01, -TW02 and -TW04 cells) were grown in Dulbecco's modified Eagle's medium as previously described. 16 Figure 7. TNFAIP2 associates with actin and modulates the formation of actin protrusions. (a) NPC-TW02 cells were pretreated with control or TNFAIP2 siRNAs for 24 h and then seeded onto coverslips. After incubation for 48 h, the cells were fixed and co-stained for endogenous TNFAIP2 and actin filaments using a specific TNFAIP2 antibody and TRITC-conjugated phalloidin, respectively. Nuclei were stained with DAPI. Images were acquired using a ZEISS LSM510 META laser-scanning confocal microscope (Carl Zeiss) with a Â 63/1.32 NA oil-immersion objective. Scale bar, 20 mm. Inset shows images acquired at higher magnification. (b) The siRNA-mediated depletion of TNFAIP2 proteins was confirmed using western blotting. The total amounts of actin were unchanged. (c and d) Quantitative analysis of the actin protrusions. Wholeslide images of NPC-TW02 cells treated as described above were acquired from 16 random fields within the cell area using an IN Cell Analyzer 2000 (GE Healthcare Life Sciences). The images were subsequently processed for quantitative analysis using the Developer Toolbox 1.9.1 software (GE Healthcare Life Sciences), as detailed in the Materials and methods and Supplementary Information. In sum, 2795 control siRNAand 2975 TNFAIP2 siRNA-treated cells were acquired and the percentages of cells with certain types of actin protrusions (c) and the average lengths of the actin protrusions (d) were calculated and compared. The data are presented as the mean ± s.d. (e) Association of TNFAIP2 with actin. Cell extracts from NPC-TW02 cells were subjected to co-immunoprecipitation assays using a specific TNFAIP2 antibody coupled with protein G beads. The precipitated protein complexes were subsequently analyzed using western blotting with TNFAIP2 and actin antibodies.
HK1 and HK1-EBV cells were maintained in RPMI 1640 supplemented with 10% fetal bovine serum and G418 (500 mg/ml; for HK1-EBV to maintain the EBV genome). The inhibitors, BAY11-7082, SP600125, SB203580 and PD98059, were purchased from Calbiochem (San Diego, CA, USA). The recombinant TNFa, IFNa and IFNg proteins were purchased from PeproTech (Rocky Hill, NJ, USA). Unless specified elsewhere, the transfection was performed using a CaPO 4 -based method as previously described. 27 Figure 8. TNFAIP2 has a migrating-promoting effect that contributes to LMP1-induced cell motility. (a) NPC-TW02 cells pretransfected with pCMV-Flag or pFlag-LMP1 for 6 h were further transfected with control-or TNFAIP2-targeting siRNA. After 24 h, the cells were trypsinized and seeded into a chemotaxis chamber for transwell migration assays (detailed in the Materials and methods). Representative images of migrated cells were taken at Â 50 magnification. (b) The numbers of migrated cells are presented as the mean±s.d. from at least three independent experiments. The expression of LMP1 and the depletion of TNFAIP2 were confirmed using western blotting; *Po0.05. (c) NPC-TW02 cells were first transfected with pEGFP or pEGFP-LMP1, followed by transfection with control-or TNFAIP2-targeting siRNA, as described above. After 24 h, the cells were trypsinized and seeded onto coverslips, grown for another 24 h and then fixed for staining of actin filaments (F-actin) and nuclei using TRITC-conjugated phalloidin and DAPI, respectively. Images were acquired using a confocal microscope. The morphology of EGFP-expressing cells was revealed by DIC images. Scale bar, 20 mm. (d) NPC-TW02 cells were transfected with pIRES2-EGFP (IRES) or pTNFAIP2-IRES2-EGFP, and subjected to transwell migration assays as described above. (e) Quantification of migrated cells. The data are presented as the mean±s.d. from at least three independent experiments. The ectopic expression of TNFAIP2 was confirmed using western blotting; *Po0.05. (f ) NPC-TW02 cells were transfected with pIRES2-EGFP (IRES) or pTNFAIP2-IRES-EGFP (TNFAIP2). After 24 h, the cells were seeded onto coverslips, grown for another 24 h and then fixed for staining of actin filaments and nuclei. Images were acquired as described above. Scale bar, 20 mm.
Plasmid construction
The wild-type, truncated and mutated Flag-tagged LMP1 constructs were generated as described previously. 27 The LMP1-mCherry construct was generated by replacing the C-terminal Flag tag of pcDNA3.1-LMP1-Flag 56 with the sequence encoding a red-fluorescence protein (mCherry; Invitrogen, Carlsbad, CA, USA). To generate the TNFAIP2 promoter constructs, the sequences upstream of the TNFAIP2 gene, À 4002 to þ 121 bp and À 3797 to þ 121 bp, were cloned into the pGL3-basic plasmid (Promega, Madison, WI, USA). The conserved NF-kB-binding site sequence (5 0 -GGGAAATTCC-3 0 ) was mutated to 5 0 -TACAAAGTCC-3 0 and 5 0 -TACAAAGGAA-3 0 by site-directed mutagenesis to generate NF-kB-m1 and NF-kB-m2, respectively. Also see Supplementary Information.
Quantitative reverse transcription (RT)-PCR
Total mRNA was isolated from NPC cells using the TRIzol reagent (Invitrogen), and reverse transcribed using the ImProm-II system (Promega) with an Oligo(dT) 15 primer. Quantitative RT-PCR was performed using the FastStart DNA Master SYBR Green I reagent (Roche Diagnostics, Mannheim, Germany) in a Light-Cycler instrument (Roche Diagnostics). The amounts of mRNA data were normalized with respect to those of GADPH. Also see Supplementary Information.
Western blotting
Western blotting was performed as previously described. 27 The utilized antibodies are as follows: anti-TNFAIP2 (F-6), anti-tubulin (clone DM1A), anti-I-kBa (C-21), anti-c-Jun (H-79), anti-Erk1/2 (C-16) and anti-p65 (F-6) purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA); anti-Flag (clone M2) purchased from Sigma-Aldrich (St Louis, MO, USA); anti-GAPDH (6C5) purchased from Abcam (Cambridge, MA, USA); anti-p38a MAPK (no. 9218) and anti-p38b MAPK (no. 2339) purchased from Cell Signaling Technology (Beverly, MA, USA); anti-actin (MAB1501) purchased from Chemicon (Temecula, CA, USA). The monoclonal anti-LMP1 antibody (S12) was affinity-purified from a hybridoma.
RNA interference
SMARTpool reagents containing four 21-bp RNA duplexes (siRNAs) targeting p65, c-Jun, p38a, p38b, ERK1, ERK2 or TNFAIP2 were purchased from Dharmacon (Lafayette, CO, USA). The nontargeting duplexes (control siRNA) were synthesized by Research Biolabs (Singapore, Singapore). Cells were transfected with 75 pmol dsRNA duplexes using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions.
Immunohistochemistry and in situ hybridization
Immunohistochemical staining of LMP1 and in situ hybridization for the detection of EBV-encoded RNA transcripts were performed as described previously. 10 For the detection of TNFAIP2 and activated p65, tissue sections were stained with antibodies against TNFAIP2 (F-6; 1:100; Santa Cruz Biotechnology) and NF-kB-p65 NLS (12H11; 1:100; Chemicon Millipore, Watford, UK) using an automatic immunohistochemicalstaining device (Bond, Vision BioSystems, Australia, Australia) as described previously. 23, 27 The results were evaluated by a pathologist who was blinded with respect to the pathological backgrounds of the patients. The percentage of cancerous cells that stained positive for each examined protein was scored following a 0-to-10 scoring strategy that was independent of the staining intensity. A score of '0' indicated that no staining was observed in cancerous cells, whereas a score of '10' meant that 100% of cancerous cells were positive for staining.
Luciferase reporter assay
Cells were transfected with 0.2 mg of pCMV-Flag or pFlag-LMP1, plus 0.2 mg of TNFAIP2 promoter-reporter plasmids and 2 ng of Renilla-encoding plasmids (internal control), using Lipofectamine (Invitrogen) according to the manufacturer's instructions. At 24 h post transfection, cell lysates were harvested and luciferase reporter assays were performed using the Dual-Luciferase Reporter Assay System (Promega). The reporter activity was calculated as a ratio of firefly luminescence (from the promoter reporter) normalized with respect to Renilla luminescence.
Immunofluorescence microscopy
For the expression of LMP1 or ectopic TNFAIP2, cells were transfected with 1 mg of pcDNA3.1-LMP1-mCherry or pEGFP-TNFAIP2 using FuGENE (Roche Applied Science). For knockdown experiments, cells were transfected with control-or TNFAIP2-specific siRNAs (37.5 nM) using Lipofectamine 2000 (Invitrogen). After 24 or 48 h, the cells were trypsinized and seeded onto coverslips. After 24 h, the cells were fixed and stained with an anti-TNFAIP2 antibody followed by an Alexa Fluor 488-conjugated secondary antibody (Molecular Probes, Invitrogen, Carlsbad, CA, USA). For actin filament staining, cells were incubated with TRITC-conjugated phalloidin (SigmaAldrich) for 1 h after fixation. Nuclei were stained with DAPI (SigmaAldrich). All coverslides were mounted with the Fluoro-Gel (Electron Microscopy Sciences, Hatfield, PA, USA) and visualized using a ZEISS LSM510 META confocal microscope (Carl Zeiss, Jena, Germany) with a Â 63/1.32 NA oil-immersion objective. Also see Supplementary Information.
High-content analysis of actin-based protrusion formation
To comprehensively analyze the TNFAIP2-associated formation of actin protrusions, we treated NPC-TW02 cells with control or TNFAIP2 siRNA and co-stained the cells with TRITC-phalloidin and DAPI as described above. Images were acquired using an IN Cell Analyzer 2000 with a Â 20/0.45 NA Nikon objective (Nikon, Tokyo, Japan). For each group, images were randomly acquired from 16 fields within the cell area (100-200 cells per field). During acquisition, images were captured with two-dimensional deconvolution to enhance the feature resolution. Deconvoluted images were then analyzed using the Developer Toolbox 1.9.1 software (GE Healthcare Life Sciences) and processed for object-based segmentation. The average length of actin protrusions and the percentage of cells with certain types of actin protrusions were calculated between control and TNFAIP2 siRNA-treated cells. Also see Supplementary Information.
Co-immunoprecipitation assays
NPC-TW02 cells were lysed and subjected to co-immunoprecipitation assays as described previously. 16 Cell lysates (1 mg protein) were incubated with 1 mg of anti-TNFAIP2 antibody (Santa Cruz Biotechnology) together with 40 ml of a 50% (w/v) slurry of protein G beads (Amersham Biosciences, Figure 9 . Model for the LMP1-mediated upregulation of TNFAIP2 and its role in NPC cells. LMP1 induces TNFAIP2 expression mainly through the CTAR2 domain, which transduces canonical signaling to activate NF-kB. The activated NF-kB, in turn, translocates into the nucleus and binds to a consensus NF-kB site within the TNFAIP2 promoter, upregulating the transcription of TNFAIP2. Inhibition of NF-kB activation with an inhibitor (BAY11-7082), a dominantnegative mutant of I-kBa, or siRNA-mediated p65 depletion abolishes the induction of TNFAIP2 by LMP1. Functionally, the elevated expression of TNFAIP2 contributes to LMP1-induced cell motility, probably by modulating actin organization.
Piscataway, NJ, USA). The mixtures were incubated overnight at 4 1C with rotation and then washed twice with Tris buffer A (20 mM Tris-HCl, pH 7.5, 250 mM NaCl, 0.5 mM DTT) and four times with Tris buffer B (20 mM Tris-HCl, pH 7.5, 0.5 mM DTT). The resulting proteins were eluted with sodium dodecyl sulphate sample buffer and analyzed using western blotting.
Cell-migration assays
Cell-migration abilities were evaluated using a chemotaxis chamber (BD Falcon, BD Biosciences, San Jose, CA, USA) as previously described. 16 The cells were harvested at 24 h post transfection, resuspended in 100 ml of serum-free medium and then loaded into the upper chamber of the apparatus. The lower chamber contained 10% fetal bovine serum medium. After a 16-h incubation, the cells that had migrated to the opposite side of the upper chamber were fixed and stained for 30 min with 1% crystal violet, 1.85% formaldehyde and 70% ethanol, and then washed with ddH 2 O for the removal of background. Images of each group were taken from 10 random fields at Â 50 magnification and the migrated cells were counted.
Statistical analyses
Statistical analyses were performed using the SPSS 18.0 statistical software package. For cell-based experiments, significance between groups was calculated using a two-tailed paired t-test. For clinical specimens, significance between groups was calculated using a two-tailed MannWhitney test. Correlation between groups was analyzed using a two-tailed Spearman's test. A P-value o0.05 was considered statistically significant.
